Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Purification and characterization of a recombinant Yersinia pestis V-F1 "Reversed" fusion protein for use as a new subunit vaccine against plague.

Goodin JL, Powell BS, Enama JT, Raab RW, McKown RL, Coffman GL, Andrews GP.

Protein Expr Purif. 2011 Mar;76(1):136-44. doi: 10.1016/j.pep.2010.10.011. Epub 2010 Nov 3.

PMID:
21055471
2.

Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.

Little SF, Webster WM, Wilhelm H, Fisher D, Norris SL, Powell BS, Enama J, Adamovicz JJ.

Vaccine. 2010 Jan 22;28(4):934-9. doi: 10.1016/j.vaccine.2009.10.143. Epub 2009 Nov 17.

PMID:
19925906
3.

Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice.

Little SF, Webster WM, Wilhelm H, Powell B, Enama J, Adamovicz JJ.

Biologicals. 2008 Sep;36(5):287-95. doi: 10.1016/j.biologicals.2008.03.001. Epub 2008 May 16.

PMID:
18485733
4.

Vaccination with F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis.

Rocke TE, Smith S, Marinari P, Kreeger J, Enama JT, Powell BS.

J Wildl Dis. 2008 Jan;44(1):1-7.

PMID:
18263816
5.

Three-dimensional and thermal surface imaging produces reliable measures of joint shape and temperature: a potential tool for quantifying arthritis.

Spalding SJ, Kwoh CK, Boudreau R, Enama J, Lunich J, Huber D, Denes L, Hirsch R.

Arthritis Res Ther. 2008;10(1):R10. doi: 10.1186/ar2360. Epub 2008 Jan 23.

6.

Multiple asparagine deamidation of Bacillus anthracis protective antigen causes charge isoforms whose complexity correlates with reduced biological activity.

Powell BS, Enama JT, Ribot WJ, Webster W, Little S, Hoover T, Adamovicz JJ, Andrews GP.

Proteins. 2007 Aug 1;68(2):458-79.

PMID:
17469195
7.

Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.

Goodin JL, Nellis DF, Powell BS, Vyas VV, Enama JT, Wang LC, Clark PK, Giardina SL, Adamovicz JJ, Michiel DF.

Protein Expr Purif. 2007 May;53(1):63-79. Epub 2006 Dec 31.

8.

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ.

Biotechnol Prog. 2005 Sep-Oct;21(5):1490-510.

PMID:
16209555
9.

Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum.

Goodin JL, Raab RW, McKown RL, Coffman GL, Powell BS, Enama JT, Ligon JA, Andrews GP.

Protein Expr Purif. 2005 Mar;40(1):152-63.

PMID:
15721783
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk